Off-topic: Depression gone after participating in 5 day Tony Robins event
The Exciting Emergence of Regenerative Medicine - Mercola May 2022
📄 Download the PDF from VitaminDWiki
"A Stanford clinical research study of Robbins’ “Date With Destiny” program found 100% of participants with clinical depression were symptom-free 30 days after completion of the five-and-a-half-day course"
"During his career, Robbins has coached more than 10 million people through group events, and more than 100 million digitally. Pre-COVID, he would visit, on average, 125 cities in more than a dozen countries each year. "
Robins before going online..." would normally go see a quarter of a million people over most years, some years a million people, but now, we had one the other day for six days; 800,000 people signed up, and then there are people joining them because it's in their home."
You can get a taste of the 6 day event People can see it if they go to Netflix — a version of one. ‘Tony Robbins: I'm Not Your Guru,’ compresses it. It’s an hour and 45 minutes. *Note Netflix gives a 30 day free trial
VitaminDWiki pages with STEM CELLS in title (9 as of May 2022)
This list is automatcially updated
{LIST()}
Intervention of Vitamin D for Depression
{category}
Meta-analyses of Vitamin D and Depression
{category}
VitaminDWiki - Depression summary
{include}
2022 Book: Life Force by Robins - with Table of Contents
L ife Force: How New Breakthroughs in Precision Medicine Can Transform the Quality of Your Life & Those You Love
Hardcover – February 8, 2022 Amazon $17
He likes stem cells made from the recpients own blood (mentioned 409 times in the book)
Vitamin D is mentioned 11 times in the book
Table of Contents

2022 video of T. Robbins, P. Diamandis and R. Patrick on Life extension
00:10:58 - Tony Robbins and Peter Diamandis discuss their lifestyle habits
00:19:17 - Early detection tests, like the "annual digital upload" (a full-body MRI) and GRAIL (a comprehensive cancer screening blood test).
00:37:32 - How interrupted cellular reprogramming may unleash the power of Yamanaka stem cell factors to reverse aging.
00:45:14 - Longevity escape velocity
01:04:44 - Therapeutic plasma exchange
01:12:32 - How scientists are progressing toward 3D printing of complex organs from pluripotent stem cells.
01:14:29 - The societal implications that may accompany lifespan-extending technologies.
01:17:51 - Peter's expectations on the most likely technical approach to win the $101 million age-reversal X Prize.
01:17:51 - What gene therapy costs and how scaling this technology may make it affordable for everyone.
01:19:39 - How mRNA vaccine technology may be applied to counter immunosenescence – the exhaustion of the aging immune system.
Scientists mentioned
Robert Hariri, MD, PhD, prominent stem cell researcher; co-author on Life Force
Carl June, MD, a pioneer of CAR T-cell Therapy
Jeff Huber, founding CEO of GRAIL, Inc.
Juan Carlos Izpisúa Belmonte, PhD, a pioneer in in vivo tissue reprogramming
George Church, PhD, the father of synthetic biology
Jeff Bezos and Yuri Milner, purported investors in Altos Labs
Morgan Levine, PhD, epigenetics researcher and founding principal investigator at Altos Labs
Brian Armstrong, Coinbase and NewLimit
Ray Kurzweil, investor and futurist
Matthew Walker, PhD, sleep expert (watch our interview together)
Deepak Srivatsava, MD, president of Gladstone Institutes
David Sinclair, PhD, aging researcher (watch our interview together)
Anthony Atala, MD, pioneering tissue researcher and engineer (watch this presentation on autologous organ transplantation)
Dean Kamen, an American engineer known for his invention of the Segway
Martine Rothblatt, PhD, creator of SiriusXM radio Craig Venter, co-founder of Human Longevity, Inc.
Other resources
Fountain Life, using precision diagnostics to facilitate early detection of disease
Human Longevity, Inc., using machine learning to help develop new ways to fight diseases associated with aging
Health Nucleus, provider of precision health care powered by genomics and metabolomics
Biosplice, manufacturers of osteoarthritis small molecule SM04690
Cleerly, Inc., provider of Coronary CT scans
EdenRoc Sciences, developers of MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide
Vaxxinity, developers of monoclonal antibody vaccine technology targeting disease-associated endogenous proteins